Similarly to Chen et al. [22], we observed prolonged surgical times in the control group (no pretreatment with intravitreal anti-VEGF), and we did not find any differences in the prevalence of secondary retinal detachments. The gene discussed is VEGFA; the disease is retinal detachment.